David is a seasoned healthcare investment banker at EF Hutton, with a unique background that began in science. He holds a PhD in Chemical Engineering and AI, and formerly served as a scientist at Novartis and Pfizer before transitioning to finance. He has executed over 100 transactions valued at over $10 billion.
Outside of his finance career, David is deeply committed to advancing cancer research, serving as an advisor to the Cancer Prevention & Research Institute of Texas (CPRIT) and the presidential "Cancer Moonshot" initiative. He also serves on the board of the Lymphatic Education & Research Network.
Unique fact: David founded an AI Pathology platform at Mount Sinai Hospital, which was later acquired by Philips.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.